Hand, Foot, and Mouth Disease As An Unusual Cutaneous Viral Infection Post-Rituximab: A Rare Observation

Paridhi Vaidh; Debasmita Behera; Chinmoy  Raj; Farheen  Begum

doi:10.5826/dpc.1601a6075

Hand, Foot, and Mouth Disease As An Unusual Cutaneous Viral Infection Post-Rituximab: A Rare Observation

Authors

Paridhi Vaidh Department of Dermatology, Venereology and Leprosy, KIMS Hospital, Bhubaneswar
Debasmita Behera Department of Dermatology, Venereology and Leprosy, KIMS Hospital, Bhubaneswar
Chinmoy Raj Department of Dermatology, Venereology and Leprosy, KIMS Hospital, Bhubaneswar
Farheen Begum Department of Dermatology, Venereology and Leprosy, KIMS Hospital, Bhubaneswar

Keywords:

Rituximab, pemphigus, hand foot mouth disease

References

Porro AM, Seque CA, Ferreira MCC, Enokihara MMSES. Pemphigus vulgaris. An Bras Dermatol. 2019 Jul 29;94(3):264-278. doi: 10.1590/abd1806-4841.20199011. PMID: 31365654; PMCID: PMC6668932.

Kridin K, Mruwat N, Amber KT, Ludwig RJ. Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study. Br J Dermatol. 2023 Mar 30;188(4):499-505. DOI: 10.1093/bjd/ljac118. PMID: 36763798.

Cazzaniga S, Naldi L, Borradori L. Rituximab and risk of infections in patients with pemphigus: answers from a global population-based cohort study. Br J Dermatol. 2023 Mar 30;188(4):454-455. DOI: 10.1093/bjd/ljad005. PMID: 36722006.

Cameron Smail R, O'Neill JH, Andresen D. Brainstem encephalitis caused by Coxsackie A16 virus in a rituximab-immunosuppressed patient. BMJ Case Rep. 2019 Aug 26;12(8):e230177. DOI: 10.1136/bcr-2019-230177. PMID: 31451462; PMCID: PMC6720565.

Strandmoe AL, Bremer J, Diercks GFH, et al. Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment. Br J Dermatol. 2024 Jul 16;191(2):164-176. DOI: 10.1093/bjd/ljae107. PMID: 38504438.